Description
Recombinant monoclonal antibody to IL-17. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma MCAF5352A (Afasevikumab).
Target
IL-17
Target Alias Names
IL17, IL-17A, IL17A, CTLA8, Interleukin-17A, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8, IL17F, IL-17F, Interleukin-17F, IL-17F, Cytokine ML-1, IL-17AA, IL-17AF, IL-17FF
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression